Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Retrospective Analysis of Genomic Landscape of ALK Positive NSCLC Prior to Ceritinib, and at Disease Progression Following Ceritinib

NCT02554591 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.

NCT NCT02554591
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02554591 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Retrospective Analysis of Genomic Landscape of ALK Positive NSCLC Prior to Ceritinib, and at Disease Progression Following Ceritinib
Lead sponsor
Washington University School of Medicine
Phase
Observational
Overall status
Terminated
Start date
September 16, 2015
Completion date
February 28, 2018
Enrollment
6 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

carcinoma, non-small-cell lung, non-small cell lung cancer, non-small lung cancer